Introduction Angiosarcoma after breast cancer conservative treatment is extremely rare pathology and its early diagnostic is complicated. Due to rarity of this patology, there is still no standard approach for treatment. The aim of this article is to present a clinical case of radiation-associated angiosarcoma (RAAS) after breast cancer conservative treatment and review the latest literature sources. Case report This case report presents 66-year-old white postmenopausal women diagnosed with left breast cancer stage I (pT1cN0M0). Breast preserving operation was performed and patient received adjuvant radiotherapy (50 Gy). After 5 years of the follow-up, RAAS of the irradiated left breast was diagnosed. The clinical features of this rare occu...
Secondary angiosarcoma of the breast is a rare but severe long-term complication of breast cancer tr...
Secondary angiosarcoma of the breast is a rare but severe long-term complication of breast cancer tr...
AimThe aim of this paper is to summarize the treatment outputs of secondary angiosarcoma after breas...
In the last couple of decades, breast conservation therapy, which utilizes a combination of surgery,...
Abstract Background Radiation-associated angiosarcoma (RAAS) is a rare subtype of secondary angiosar...
Background Radiation induced angiosarcoma (RIAS) of the breast is a rare and aggressive complication...
AbstractINTRODUCTIONAngiosarcoma is a rare tumor of the breast. Secondary angiosarcoma of the breast...
Secondary breast angiosarcoma is a known but rare late side-effect of breast cancer radiotherapy. He...
Breast angiosarcoma (BAS) is an extremely rare and poorly studied neoplasm, the etiology of primary ...
Radiation-induced breast angiosarcoma is a severe but rare late complication in the breast-preservin...
Abstract Background The incidence of radiation-associated angiosarcoma (RAA) of the breast has been ...
Angiosarcoma (AS) is a rare, aggressive tumour of endothelial origin occurring in various clinical s...
Angiosarcoma of residual breast, arising after conservative surgery and radiotherapy for early breas...
Abstract Background Radiogenic angiosarcoma of the breast (RASB) is a rare late sequela of local irr...
International audienceBreast angiosarcoma is a rare but serious complication of radiotherapy. We rep...
Secondary angiosarcoma of the breast is a rare but severe long-term complication of breast cancer tr...
Secondary angiosarcoma of the breast is a rare but severe long-term complication of breast cancer tr...
AimThe aim of this paper is to summarize the treatment outputs of secondary angiosarcoma after breas...
In the last couple of decades, breast conservation therapy, which utilizes a combination of surgery,...
Abstract Background Radiation-associated angiosarcoma (RAAS) is a rare subtype of secondary angiosar...
Background Radiation induced angiosarcoma (RIAS) of the breast is a rare and aggressive complication...
AbstractINTRODUCTIONAngiosarcoma is a rare tumor of the breast. Secondary angiosarcoma of the breast...
Secondary breast angiosarcoma is a known but rare late side-effect of breast cancer radiotherapy. He...
Breast angiosarcoma (BAS) is an extremely rare and poorly studied neoplasm, the etiology of primary ...
Radiation-induced breast angiosarcoma is a severe but rare late complication in the breast-preservin...
Abstract Background The incidence of radiation-associated angiosarcoma (RAA) of the breast has been ...
Angiosarcoma (AS) is a rare, aggressive tumour of endothelial origin occurring in various clinical s...
Angiosarcoma of residual breast, arising after conservative surgery and radiotherapy for early breas...
Abstract Background Radiogenic angiosarcoma of the breast (RASB) is a rare late sequela of local irr...
International audienceBreast angiosarcoma is a rare but serious complication of radiotherapy. We rep...
Secondary angiosarcoma of the breast is a rare but severe long-term complication of breast cancer tr...
Secondary angiosarcoma of the breast is a rare but severe long-term complication of breast cancer tr...
AimThe aim of this paper is to summarize the treatment outputs of secondary angiosarcoma after breas...